Found: 12
Select item for more details and to access through your institution.
Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 433, doi. 10.1007/s00280-002-0517-4
- By:
- Publication type:
- Article
Dosing sequence-dependent pharmacokinetic interaction of oxaliplatin with paclitaxel in the rat.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 445, doi. 10.1007/s00280-002-0531-6
- By:
- Publication type:
- Article
Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The raltitrexed-vinorelbine combination: a phase I pharmacokinetic and pharmacodynamic trial in advanced breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 459, doi. 10.1007/s00280-002-0519-2
- By:
- Publication type:
- Article
Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 473, doi. 10.1007/s00280-002-0515-6
- By:
- Publication type:
- Article
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 479, doi. 10.1007/s00280-002-0507-6
- By:
- Publication type:
- Article
Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 490, doi. 10.1007/s00280-002-0530-7
- By:
- Publication type:
- Article
Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 501, doi. 10.1007/s00280-002-0521-8
- By:
- Publication type:
- Article
The doxorubicin-cardioprotective drug dexrazoxane undergoes metabolism in the rat to its metal ion-chelating form ADR-925.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 509, doi. 10.1007/s00280-002-0538-z
- By:
- Publication type:
- Article
Development of an optimal pharmacokinetic sampling schedule for rubitecan administered orally in a daily times five schedule.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 6, p. 514, doi. 10.1007/s00280-002-0516-5
- By:
- Publication type:
- Article